Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.66 |
| ▸ | FYN | P06241 | 1/20 | 0.55 |
| ▸ | ABL1 | P00519 | 2/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.53 |
| ▸ | BCR | P11274 | 2/20 | 0.53 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.52 |
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.52 |
| ▸ | IDH1 | O75874 | 1/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2604700 | 1.00 | MAOB (0.66) | MAOBFYNABL1ABCB1BCR | |
| SCHEMBL31222694 | 1.00 | MAOB (0.66) | MAOBFYNABL1ABCB1BCR | |
| SCHEMBL2604702 | 0.89 | ABL1 (0.62) | MAOBABL1ABCB1BCRHDAC4 | |
| SCHEMBL2604703 | 0.88 | MAOB (0.56) | MAOBFYNABL1ABCB1BCR | |
| SCHEMBL4937029 | 0.87 | FYN (0.56) | MAOBFYNHSD17B2HDAC4HDAC8 | |
| SCHEMBL1180343 | 0.84 | ABL1 (0.69) | MAOBABL1ABCB1BCRHDAC4 | |
| SCHEMBL13952331 | 0.84 | MAOB (0.68) | MAOBABL1ABCB1BCRHSD17B2 | |
| SCHEMBL5556429 | 0.84 | MAOB (0.78) | MAOBABL1ABCB1BCRHSD17B2 | |
| SCHEMBL26784208 | 0.83 | ABL1 (0.62) | MAOBABL1ABCB1BCRHSD17B2 | |
| SCHEMBL4759655 | 0.83 | RXRA (0.63) | MAOBSLC13A5MAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119013017-A | Pharmaceutical composition for treating cancer comprising an anticancer agent and a novel compound having an inhibitory activity on prostaglandin E2 receptor | 治纳辅医药科技有限公司 | 2024-11-22 | — | — | CN | disclosed |